- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking CQV Specialist II… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Operations Associate… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Operations Process… more
- Legend Biotech USA, Inc. (Philadelphia, PA)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Sr. Director of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Financial Analyst… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QA Document… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QA Batch… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QC Specialist,… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Manager, Site… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy . From our three R&D sites around the world, we apply these ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QC Investigations… more
Related Job Searches:
Administrative Assistant Immunology Immunotherapy,
Associate Researcher Immunology Immunotherapy,
Bioinformatician Immunology Immunotherapy,
Director Immunotherapy Immuno Oncology,
Endowed Director Cellular Immunotherapy,
Immunotherapy Nurse Coordinator,
Pediatric Immunotherapy Clinical Assistant,
Senior Scientist Immunology Immunotherapy